Back to Search Start Over

Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia.

Authors :
Dansky HM
Bloomfield D
Gibbons P
Liu S
Sisk CM
Tribble D
McKenney JM
Littlejohn TW 3rd
Mitchel Y
Source :
American Heart Journal; Oct2011, Vol. 162 Issue 4, p708-716, 9p
Publication Year :
2011

Details

Language :
English
ISSN :
00028703
Volume :
162
Issue :
4
Database :
Supplemental Index
Journal :
American Heart Journal
Publication Type :
Academic Journal
Accession number :
104586723